Ovarian Cancer Trial, Recruiting NCT06017557 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06017557
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are being treated at one of the participating hospitals: Fondazione Policlinico Gemelli Hospital in Rome, Italy; Trillium-Credit Valley Hospital in Mississauga, Canada; or Princess Margaret Cancer Centre in Toronto, Canada
  • You are healthy enough to undergo major surgery to remove as much of the cancer as possible
  • You have been newly diagnosed with suspected Stage III or Stage IV ovarian cancer (meaning the cancer has spread beyond the ovaries)
  • You are scheduled for surgery after first receiving chemotherapy to shrink the cancer (sometimes called "interval surgery")

Who may not be able to join:

  • Your cancer has been found to be at an earlier stage (Stage I or II), meaning it is still mostly confined to the pelvic area
  • You are not well enough to have surgery
  • There is not enough information available about your surgery results or cancer details
  • Your ovarian cancer is of certain specific types, such as low-grade serous, clear cell, mucinous, or non-epithelial subtypes — if this information is known (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anna Fagotti, Prof, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: 416-946-4501

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 January 2023
Est. completion
15 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

a) Number of Participants with Treatment Diagnostic Laparoscopy assessed by Predictive Index Value.; b)Number of Participants with Treatment Diagnostic Laparoscopy assessed by utilizing machine learning and computer vision models to analyze images and videos

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov